Skip to main content
. 2017 Sep 5;5(1):55–64. doi: 10.14283/jpad.2017.31

Table 1.

Patient and caregiver characteristics

Characteristic AD dementia severity
p Value1
Overall population
Mild Moderate Moderately severe/severe
Patients
No. of patients 29 80 89 198
Age, years (mean [SD]) 76.2 (7.12) 77.0 (7.65) 78.3 (6.85) 0.290 77.5 (7.23)
Sex, n (%) female 14 (48.3) 49 (61.3) 56 (62.9) 0.364 119 (60.1)
Time since diagnosis, years (mean [SD]) 1.6 (1.55) 1.5 (1.69) 2.5 (1.99) <0.001 2.0 (1.88)
Fell in last 3 months, n (%) yes 0 (0.0) 13 (16.3) 16 (18.0) 0.052 29 (14.6)
Neuropsychological assessment in last 6 months, n (%) yes 15 (51.7) 58 (72.5) 47 (52.8) 0.019 120 (60.6)
Marital status, married/cohabiting, n (%) 22 (75.9) 55 (68.8) 51 (57.3) 0.0702 128 (64.6)
Living location, n (%) urban 27 (93.1) 74 (92.5) 79 (88.8) 0.6363 180 (90.9)
Living in own home, n (%) 27 (96.4) 78 (97.5) 81 (93.1) 0.3134 186 (95.4)
Education, years (mean [SD]) 8.8 (4.81) 7.9 (4.01) 6.4 (3.94) 0.008 7.3 (4.18)
Comorbidities, n (%) yes 26 (89.7) 70 (87.5) 73 (82.0) 0.471 169 (85.4)
Patients receiving any psychiatric/hypnotic treatment, n (%) 10 (34.5) 33 (41.3) 47 (52.8) 0.142 90 (45.5)
 Antidepressants 9 (31.0) 27 (33.8) 35 (39.3) 0.485 71 (35.9)
 Antipsychotics 1 (3.4) 4 (5.0) 10 (11.2) 0.469 15 (7.6)
 Anxiolytics, sedatives, hypnotics 1 (3.4) 10 (12.5) 9 (10.1) 0.310 20 (10.1)
Patients receiving any AD treatment, n (%) 21 (75.0) 68 (86.1) 81 (96.4) 0.004 170 (89.0)
Category/type of AD treatment, n (%) of patients receiving AD treatment 0.086
 One AchE inhibitor 13 (61.9) 48 (70.6) 44 (54.3) 105 (61.8)
 Memantine only 7 (33.3) 13 (19.1) 19 (23.5) 39 (22.9)
 One AChE inhibitor + memantine 1 (4.8) 7 (10.3) 18 (22.2) 26 (15.3)
 Rivastigmine5 6 (28.6) 28 (41.2) 28 (34.6) 0.513 62 (36.5)
 Galantamine5 0 (0.0) 1 (1.5) 1 (1.2) 0.860 2 (1.2)
 Donezepil5 8 (38.1) 26 (38.2) 33 (40.7) 0.945 67 (39.4)
 Memantine5 8 (38.1) 20 (29.4) 37 (45.7) 0.128 65 (38.2)
Caregivers
No. of caregivers 29 80 89 198
Age, years (mean [SD]) 61.7 (10.96) 61.7 (13.37) 62.3 (12.16) 0.939 62.0 (12.46)
Sex, n (%) female 19 (67.9) 51 (63.8) 57 (65.5) 0.921 127 (65.1)
Marital status, married/cohabiting, n (%) 24 (85.7) 68 (85.0) 72 (82.8) 0.658 164 (84.1)
Caregiver relationship to patient, n (%) 0.227
 Spouse 17 (60.7) 35 (43.8) 35 (40.2) 87 (44.6)
 Child 10 (35.7) 40 (50.0) 41 (47.1) 91 (46.7)
 Other 1 (3.6) 4 (5.0) 11 (12.6) 16 (8.2)
Caregiver lives with patient, n (%) yes 20 (71.4) 48 (60.0) 58 (66.7) 0.480 64.6
Sole caregiver, n (%) yes 17 (60.7) 25 (31.3) 20 (23.0) <0.0016 62 (31.8)

AChE=acetylcholinesterase; AD=Alzheimer's disease; ANOVA=analysis of variation; BMI=body mass index; MMSE=Mini-Mental State Examination; NA=not applicable; SD=standard deviation. Percentages calculated based on total population of severity group with available data (0–3% missing), unless stated otherwise. 1p Value for comparison between AD dementia severity groups (ANOVA for continuous variables and Cochran–Mantel–Haenszel test for categorical variables). 2p Value for comparison between AD dementia severity groups for marital status (all categories, including married/cohabiting, never married, divorced/separated and widowed). 3p Value for comparison between AD dementia severity groups for living location (urban or rural). 4p Value for comparison between AD dementia severity groups for living accommodation (all categories, including own home, intermediate forms of accommodation [not dementia-specific], dementia-specific residential accommodation and other). 5Includes all patients taking this medication, either alone or in combination with another treatment. 6p Value for comparison between AD dementia severity groups for how many other caregivers are involved in caring for the patient (0, 1, 2, 3 or ≥4). ‘Mild’ AD dementia severity = MMSE score of 21–26 points; ‘Moderate’ AD dementia severity = MMSE score of 15–20 points; ‘Moderately severe/severe’ AD dementia severity = MMSE score of <15 points.